share_log

BRIEF-Orchard Therapeutics Says $150 Mln Strategic Financing Supports Execution Into First Half Of 2023

路透社 ·  Mar 2, 2021 20:10
March 2 (Reuters) - Orchard Therapeutics PLC :
   * ORCHARD THERAPEUTICS REPORTS 2020 FINANCIAL RESULTS AND REVIEWS RECENT ACCOMPLISHMENTS
   * ORCHARD THERAPEUTICS PLC - $150 MILLION STRATEGIC FINANCING SUPPORTS EXECUTION INTO FIRST HALF OF 2023
   * ORCHARD THERAPEUTICS PLC - OTL-200 U.S. FILING STRATEGY FOR METACHROMATIC LEUKODYSTROPHY (MLD) EXPECTED BY MID-2021

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment